The Allelic Expression of RNA Editing Gene ADARB1 in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.

Jiajia ZengLinyu HanTeng WangLinying HuangYanxiu ZhengNasha ZhangZiqiang LiMing Yang

Published in: Pharmacogenomics and personalized medicine (2023)

polymorphisms as prognostic markers in TACE therapy for HCC patients. Notably, our findings revealed that targeting the ADARB1 enzyme may be a promising therapeutic strategy in combination with TACE for HCC cases.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
crispr cas
chronic kidney disease
radiofrequency ablation
prognostic factors
genome wide
peritoneal dialysis
cancer therapy
copy number
transcription factor
gene expression